MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$347,166
EPS
-$0.09
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
(loss) income before income taxes
-539,856
1,829,298
-9,941,297
-14,711,850.5*
Income tax benefit
-34,793
-34,794
-34,793
-364,000.5*
Net (loss) income
-505,063
1,864,092
-9,906,504
-14,347,850*
Unrealized gain (loss) on foreign currency translation
157,897
570,580
49,221
2,394,905.5
Total other comprehensive income (loss)
157,897
570,580
49,221
2,394,905.5*
Total comprehensive income (loss)
-347,166
2,434,672
-9,857,283
-11,952,944.5
Basic EPS
-0.09
0.41
-4.41
-7.592
Diluted EPS
-0.09
-0.77
-4.41
-7.592
Basic Average Shares
5,411,244
4,536,235
2,246,066
1,574,455
Diluted Average Shares
5,411,244
4,536,235
2,246,066
1,574,455
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Unrealized gain (loss) on
foreign currency...
$157,897
(180.63%↑ Y/Y)
Total comprehensive
income (loss)
-$347,166
(-103.14%↓ Y/Y)
Total other
comprehensive income (loss)
$157,897
(180.63%↑ Y/Y)
Net (loss) income
-$505,063
(-104.48%↓ Y/Y)
(loss) income before
income taxes
-$539,856
(-104.83%↓ Y/Y)
Buy us a coffee
Neuphoria Therapeutics Inc. (NEUP)
Neuphoria Therapeutics Inc. (NEUP)